Abstract
A wide variety of contaminants are ingested through food, among them the pro-carcinogenic polycyclic aromatic hydrocarbon benzo[a]pyrene (BP) that is resorbed and partially metabolized in the enterocytes of the small intestine. Previous in vitro studies have revealed that BP phenols are excreted as Phase II metabolites including glucuronides and sulfates. This export is mediated by the breast cancer resistance protein (ABCG2). The ultimate carcinogenic Phase I BP metabolite anti-BP-7,8-dihydrodiol-9,10-epoxide (BPDE) can be detoxified by glutathione conjugate formation catalyzed by glutathione S-transferases. In the present study, differentiated human intestinal Caco-2 cells were used as a model for the human small intestine to investigate the detoxification of BPDE and excretion of stereoisomeric glutathione conjugates in the presence of an inhibitor of the glutathione-cleaving enzyme γ-glutamyl transpeptidase at the cell surface. The results indicate that the glutathione conjugates of BPDE are formed and excreted mainly to the apical and to a minor extent to the basolateral side of polarized Caco-2 monolayers. Inhibition studies revealed that the multidrug resistance-associated proteins (ABCCs) are involved in the transport of BPDE glutathione conjugates. Stable ABCC1, ABCC2 and ABCC3 knockdown cell lines were generated, thus making it possible to demonstrate that ABCC1 mediates the basolateral and ABCC2 the apical excretion of BPDE glutathione conjugates. In conclusion, the ultimate carcinogen BPDE is detoxified via glutathione conjugation and subsequently excreted by Caco-2 cells in both apical and basolateral directions. This finding is equivalent to a transport into feces as well as blood system in the in vivo situation.
Similar content being viewed by others
Abbreviations
- 1-MP-SG:
-
S-(1-Methylpyrenyl)glutathione
- ABC transporter:
-
ATP-binding cassette transporter
- BP:
-
Benzo[a]pyrene
- BP-7,8-diol:
-
(±)-trans-7,8-Dihydroxy-7,8-dihydrobenzo[a]pyrene
- BPDE:
-
BP-7,8-diol-9,10-epoxide
- (+)-syn-BPDE:
-
(7S,8R,9S,10R)-7,8-Dihydroxy-9,10-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene
- (−)-syn-BPDE:
-
(7R,8S,9R,10S)-7,8-Dihydroxy-9,10-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene
- (+)-anti-BPDE:
-
(7R,8S,9S,10R)-7,8-Dihydroxy-9,10-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene
- (−)-anti-BPDE:
-
(7S,8R,9R,10S)-7,8-Dihydroxy-9,10-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene
- (+)-BPD-SG:
-
(+)-10R-(S-Glutathionyl)-7S,8R,9R-trihydroxy-7,8,9,10-tetrahydrobenzo[a]pyrene
- (−)-BPD-SG:
-
(−)-10S-(S-Glutathionyl)-7R,8S,9S-trihydroxy-7,8,9,10-tetrahydrobenzo[a]pyrene
- BCRP:
-
Breast cancer resistance protein
- BSO:
-
dl-Buthionine-[S,R]-sulfoximine
- CYP:
-
Cytochrome P450 monooxygenase
- EPHX1:
-
Microsomal epoxide hydrolase
- GIT:
-
Gastrointestinal tract
- GSH:
-
Glutathione
- GST:
-
Glutathione S-transferase
- γGT:
-
γ-Glutamyl transpeptidase
- MRP:
-
Multidrug resistance-associated protein
- PAH:
-
Polycyclic aromatic hydrocarbon
- qRT-PCR:
-
Real-time quantitative PCR
References
Bréchot JM, Hurbain I, Fajac A, Daty N, Bernaudin JF (1998) Different pattern of MRP localization in ciliated and basal cells from human bronchial epithelium. J Histochem Cytochem 46:513–517
Buening MK, Wislocki PG, Levin W, Yagi H, Thakker DR, Akagi H, Koreeda M, Jerina DM, Conney AH (1978) Tumorigenicity of the optical enantiomers of the diastereomeric benzo[a]pyrene 7,8-diol-9,10-epoxides in newborn mice: exceptional activity of (+)-7beta,8alpha-dihydroxy-9alpha,10alpha-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene. Proc Natl Acad Sci USA 75:5358–5361
Buesen R, Mock M, Seidel A, Jacob J, Lampen A (2002) Interaction between metabolism and transport of benzo[a]pyrene and its metabolites in enterocytes. Toxicol Appl Pharmacol 183:168–178
Carriere V, Dussaulx E, Rousset M, Zweibaum A, Cambier D (1998) Decreased expression of gamma-glutamyltranspeptidase in the intestinal cell line Caco-2 by inducers of cytochrome P450 1A1. Biochem Pharmacol 56:817–823
Cascorbi I (2006) Role of pharmacogenetics of ATP-binding cassette transporters in the pharmacokinetics of drugs. Pharmacol Ther 112:457–473
Cejpek K, Hajslova J, Kocourek V, Tomaniova M, Cmolik J (1998) Changes in PAH levels during production of rapeseed oil. Food Addit Contam 15:563–574
Chan LM, Lowes S, Hirst BH (2004) The ABCs of drug transport in intestine and liver: efflux proteins limiting drug absorption and bioavailability. Eur J Pharm Sci 21:25–51
Ebert B, Seidel A, Lampen A (2005) Identification of BCRP as transporter of benzo[a]pyrene conjugates metabolically formed in Caco-2 cells and its induction by Ah-receptor agonists. Carcinogenesis 26:1754–1763
Evers R, Cnubben NH, Wijnholds J, van Deemter L, van Bladeren PJ, Borst P (1997) Transport of glutathione prostaglandin A conjugates by the multidrug resistance protein 1. FEBS Lett 419:112–116
Evers R, Kool M, van Deemter L, Janssen H, Calafat J, Oomen LC, Paulusma CC, Oude Elferink RP, Baas F, Schinkel AH, Borst P (1998) Drug export activity of the human canalicular multispecific organic anion transporter in polarized kidney MDCK cells expressing cMOAT (MRP2) cDNA. J Clin Invest 101:1310–1319
Fields WR, Morrow CS, Doss AJ, Sundberg K, Jernstrom B, Townsend AJ (1998) Overexpression of stably transfected human glutathione S-transferase P1-1 protects against DNA damage by benzo[a]pyrene diol-epoxide in human T47D cells. Mol Pharmacol 54:298–304
Foth H, Kahl R, Kahl GF (1988) Pharmacokinetics of low doses of benzo[a]pyrene in the rat. Food Chem Toxicol 26:45–51
Funk M, Frank H, Platt KL, Oesch F, Seidel A (1993) Synthesis and characterization of glutathione conjugates of diastereomeric bay- and fjord-region dihydrodiol epoxides. In: Garrigues P, Lamotte M (eds) Polycyclic aromatic compounds: synthesis, properties, analytical measurements, occurrence and biological effects. Gordon and Breach Science Publishers, Switzerland, pp 207–214
Gerk PM, Vore M (2002) Regulation of expression of the multidrug resistance-associated protein 2 (MRP2) and its role in drug disposition. J Pharmacol Exp Ther 302:407–415
Glatt H, Henschler R, Frank H, Seidel A, Yang C, Abu-Shqara E, Harvey RG (1993) Sulfotransferase-mediated mutagenicity of 1-hydroxymethylpyrene and 4H-cyclopenta[def]chrysen-4-ol and its enhancement by chloride anions. Carcinogenesis 14:599–602
Hirohashi T, Suzuki H, Chu XY, Tamai I, Tsuji A, Sugiyama Y (2000) Function and expression of multidrug resistance-associated protein family in human colon adenocarcinoma cells (Caco-2). J Pharmacol Exp Ther 292:265–270
Jacob J, Grimmer G (1996) Metabolism and excretion of polycyclic aromatic hydrocarbons in rat and in human. Cent Eur J Public Health 4(Suppl):33–39
Jernström B, Funk M, Frank H, Mannervik B, Seidel A (1996) Glutathione S-transferase A1-1-catalysed conjugation of bay and fjord region diol epoxides or polycyclic aromatic hydrocarbons with glutathione. Carcinogenesis 17:1491–1498
Kapitulnik J, Wislocki PG, Levin W, Yagi H, Jerina DM, Conney AH (1978) Tumorigenicity studies with diol-epoxides of benzo[a]pyrene which indicate that (+/−)-trans-7beta,8alpha-dihydroxy-9alpha,10alpha-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene is an ultimate carcinogen in newborn mice. Cancer Res 38:354–358
Keppler D (1999) Export pumps for glutathione S-conjugates. Free Radic Biol Med 27:985–991
Koreeda M, Moore PD, Wislocki PG, Levin W, Yagi H, Jerina DM (1978) Binding of benzo[a]pyrene 7,8-diol-9,10-epoxides to DNA, RNA, and protein of mouse skin occurs with high stereoselectivity. Science 199:778–781
Kruh GD, Zeng H, Rea PA, Liu G, Chen ZS, Lee K, Belinsky MG (2001) MRP subfamily transporters and resistance to anticancer agents. J Bioenerg Biomembr 33:493–501
Kushman ME, Kabler SL, Fleming MH, Ravoori S, Gupta RC, Doehmer J, Morrow CS, Townsend AJ (2007) Expression of human glutathione S-transferase P1 confers resistance to benzo[a]pyrene or benzo[a]pyrene-7,8-dihydrodiol mutagenesis, macromolecular alkylation and formation of stable N2-Gua-BPDE adducts in stably transfected V79MZ cells co-expressing hCYP1A1. Carcinogenesis 28:207–214
Leslie EM, Ki Ito, Upadhyaya P, Hecht SS, Deeley RG, Cole SPC (2001) Transport of the beta-O-glucuronide conjugate of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) by the multidrug resistance protein 1 (MRP1). J Biol Chem 276:27846–27854
Levin W, Wood AW, Yagi H, Jerina DM, Conney AH (1976) (+/−)-trans-7,8-Dihydroxy-7,8-dihydrobenzo[a]pyrene: a potent skin carcinogen when applied topically to mice. Proc Natl Acad Sci USA 73:3867–3871
Loe DW, Stewart RK, Massey TE, Deeley RG, Cole SP (1997) ATP-dependent transport of aflatoxin B1 and its glutathione conjugates by the product of the multidrug resistance protein (MRP) gene. Mol Pharmacol 51:1034–1041
McCaustland DJ, Engel JF (1975) Metabolites of polycyclic aromatic hydrocarbons. II. Synthesis of 7,8-dihydrobenzo[a]pyrene-7,8-diol and 7,8-dihydrobenzo[a]pyrene-7,8-epoxide. Tetrahedron Lett 16:2549–2552
Oude Elferink RP, Bakker CT, Jansen PL (1993) Glutathione-conjugate transport by human colon adenocarcinoma cells (Caco-2 cells). Biochem J 290:759–764
Pavek P, Merino G, Wagenaar E, Bolscher E, Novotna M, Jonker JW, Schinkel AH (2005) Human breast cancer resistance protein: interactions with steroid drugs, hormones, the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine, and transport of cimetidine. J Pharmacol Exp Ther 312:144–152
Prime-Chapman HM, Fearn RA, Cooper AE, Moore V, Hirst BH (2004) Differential multidrug resistance-associated protein 1 through 6 isoform expression and function in human intestinal epithelial Caco-2 cells. J Pharmacol Exp Ther 311:476–484
Ramesh A, Inyang F, Hood DB, Archibong AE, Knuckles ME, Nyanda AM (2001) Metabolism, bioavailability, and toxicokinetics of benzo(alpha)pyrene in F-344 rats following oral administration. Exp Toxicol Pathol 53:275–290
Ramesh A, Walker SA, Hood DB, Guillen MD, Schneider K, Weyand EH (2004) Bioavailability and risk assessment of orally ingested polycyclic aromatic hydrocarbons. Int J Toxicol 23:301–333
Renes J, de Vries EG, Nienhuis EF, Jansen PL, Muller M (1999) ATP- and glutathione-dependent transport of chemotherapeutic drugs by the multidrug resistance protein MRP1. Br J Pharmacol 126:681–688
Scharmach E, Hessel S, Niemann B, Lampen A (2009) Glutathione S-transferase expression and isoenzyme composition during cell differentiation of Caco-2 cells. Toxicology 265:122–126
Schrickx J, Lektarau Y, Fink-Gremmels J (2006) Ochratoxin A secretion by ATP-dependent membrane transporters in Caco-2 cells. Arch Toxicol 80:243–249
Seidel A, Friedberg T, Lollmann B, Schwierzok A, Funk M, Frank H, Holler R, Oesch F, Glatt H (1998) Detoxification of optically active bay- and fjord-region polycyclic aromatic hydrocarbon dihydrodiol epoxides by human glutathione transferase P1-1 expressed in Chinese hamster V79 cells. Carcinogenesis 19:1975–1981
Shirasaka Y, Konishi R, Funami N, Kadowaki Y, Nagai Y, Sakaeda T, Yamashita S (2009) Expression levels of human P-glycoprotein in in vitro cell lines: correlation between mRNA and protein levels for P-glycoprotein expressed in cells. Biopharm Drug Dispos 30:149–152
Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Goeke NM, Olson BJ, Klenk DC (1985) Measurement of protein using bicinchoninic acid. Anal Biochem 150:76–85
Srivastava SK, Watkins SC, Schuetz E, Singh SV (2002) Role of glutathione conjugate efflux in cellular protection against benzo[a]pyrene-7,8-diol-9,10-epoxide-induced DNA damage. Mol Carcinog 33:156–162
Sundberg K, Johansson AS, Stenberg G, Widersten M, Seidel A, Mannervik B, Jernstrom B (1998) Differences in the catalytic efficiencies of allelic variants of glutathione transferase P1-1 towards carcinogenic diol epoxides of polycyclic aromatic hydrocarbons. Carcinogenesis 19:433–436
Thakker DR, Yagi H, Lu AY, Levin W, Conney AH (1976) Metabolism of benzo[a]pyrene: conversion of (+/−)-trans-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene to highly mutagenic 7,8-diol-9,10-epoxides. Proc Natl Acad Sci USA 73:3381–3385
Vaidya SS, Walsh SW, Gerk PM (2009) Formation and efflux of ATP-binding cassette transporter substrate 2,4-dinitrophenyl-S-glutathione from cultured human term placental villous tissue fragments. Mol Pharm 6:1689–1702
van Bladeren PJ, Buijs W, Breimer DD, van der Gen A (1980) The synthesis of mercapturic acids and their esters. Eur J Med Chem 15:495–497
van Herwaarden AE, Wagenaar E, Karnekamp B, Merino G, Jonker JW, Schinkel AH (2006) Breast cancer resistance protein (Bcrp1/Abcg2) reduces systemic exposure of the dietary carcinogens aflatoxin B1, IQ and Trp-P-1 but also mediates their secretion into breast milk. Carcinogenesis 27:123–130
Weiss J, Theile D, Ketabi-Kiyanvash N, Lindenmaier H, Haefeli WE (2007) Inhibition of MRP1/ABCC1, MRP2/ABCC2, and MRP3/ABCC3 by nucleoside, nucleotide, and non-nucleoside reverse transcriptase inhibitors. Drug Metab Dispos 35:340–344
Wijnholds J, de Lange ECM, Scheffer GL, van den Berg D-J, Mol CAAM, van der Valk M, Schinkel AH, Scheper RJ, Breimer DD, Borst P (2000) Multidrug resistance protein 1 protects the choroid plexus epithelium and contributes to the blood-cerebrospinal fluid barrier. J Clin Invest 105:279–285
Xia CQ, Liu N, Yang D, Miwa G, Gan LS (2005) Expression, localization, and functional characteristics of breast cancer resistance protein in Caco-2 cells. Drug Metab Dispos 33:637–643
Yagi H, Thakker DR, Hernandez O, Koreeda M, Jerina DM (1977) Synthesis and reactions of the highly mutagenic 7,8-diol 9,10-epoxides of the carcinogen benzo[a]pyrene. J Am Chem Soc 99:1604–1611
Yang SK, Roller PP, Fu PP, Harvey RG, Gelboin HV (1977) Evidence for a 2,3-epoxide as an intermediate in the microsomal metabolism of benzo[a]pyrene to 3-hydroxybenzo[a]pyrene. Biochem Biophys Res Commun 77:1176–1182
Acknowledgments
We would like to thank Anja Koellner and Maja Tomic for their excellent technical support. This work was supported by the German Research Foundation DFG (grant number: LA 1177/4-2).
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hessel, S., John, A., Seidel, A. et al. Multidrug resistance-associated proteins are involved in the transport of the glutathione conjugates of the ultimate carcinogen of benzo[a]pyrene in human Caco-2 cells. Arch Toxicol 87, 269–280 (2013). https://doi.org/10.1007/s00204-012-0917-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00204-012-0917-0